THE efficacy of kanamycin for the treatment of infections due to gram-positive and gram-negative bacteria has been established, 1–11 and the hazards of injudicious administration of the drug ...

THIS report describes our experience with kanamycin § in the treatment of 25 severe and acute infections in the adult. In general, the new antimicrobial agent has been administered for two kinds of ...

Kanamycin sulfate 500mg/vial, 1g/vial; soln for IM inj or IV infusion, intraperitoneal, nebulization, irrigation after dilution; contains sulfites. Obesity: base dose on lean body mass. IM: inject ...

In Escherichia coli K12 carrying both the F factor and a determinant for kanamycin resistance (K) the association of K with F appears to be independent of that of F with the chromosome. This applies ...